NYSEAMERICAN : CPHI
China Pharma Holdings, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · China
Last price 0.6206 USD (Oct 30, 2026, 9:21 AM EDT) · Market cap 26.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 26.88M |
| Enterprise Value | 30.64M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 43.02M |
| Shares Outstanding | 43.02M |
| Shares Change (YoY) | +646.10% |
| Shares Change (QoQ) | +58.28% |
| Owned by Insiders (%) | 92.33% |
| Owned by Institutions (%) | 0.47% |
| Float | 3.30M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.87 |
| Forward PS | n/a |
| PB Ratio | 0.70 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 7.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.26 |
| Quick Ratio | 0.07 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.19 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -20.99% |
| Return on Assets (ROA) | -9.36% |
| Return on Invested Capital (ROIC) | -10.91% |
| Return on Capital Employed (ROCE) | -11.82% |
| Weighted Average Cost of Capital (WACC) | 8.95% |
| Revenue Per Employee | $18,205 |
| Profits Per Employee | -$20,813 |
| Employee Count | 215 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 2.27 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -64.81% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 0.83 |
| Relative Strength Index (RSI) | 40.66 |
| Average Volume (20 Days) | 4,192,786 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 198,256 |
| Short Previous Month | 182,610 |
| Short % of Shares Out | 0.46% |
| Short % of Float | 6.01% |
| Short Ratio (days to cover) | 0.05 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.91M |
| Gross Profit | 460,174 |
| Operating Income | -4.38M |
| Pretax Income | -4.47M |
| Net Income | -4.47M |
| EBITDA | -1.44M |
| EBIT | -4.38M |
| Loss Per Share | -$0.23 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 304,874 |
| Total Debt | 4.06M |
| Net Cash | -3.75M |
| Net Cash Per Share | -$0.09 |
| Equity (Book Value) | 36.18M |
| Book Value Per Share | 0.89 |
| Working Capital | -5.67M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -140,490 |
| Capital Expenditures | -1,065 |
| Depreciation & Amortization | 2.94M |
| Net Borrowing | -154,013 |
| Free Cash Flow | -141,555 |
| FCF Per Share | -$0.00 |
Margins
| Measure | Value |
|---|
| Gross Margin | 11.76% |
| Operating Margin | -111.82% |
| Pretax Margin | -114.33% |
| Profit Margin | -114.33% |
| EBITDA Margin | -36.81% |
| EBIT Margin | -111.82% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -646.10% |
| Shareholder Yield | -646.10% |
| Earnings Yield | -36.34% |
| FCF Yield | -0.53% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 15, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.16 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |